Vicapsys Life Sciences reported net income of -$0.24M for the quarter ended Sep 2024. This income statement covers 23 quarters of results from Mar 2019 through Sep 2024, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating items | |||||||||||||||||||||||
| Research & DevelopmentR&D | -1.00 | 0.09M | 0.01M | 0.00M | 0.00M | 0.01M | 0.01M | 0.00M | 0.01M | 0.00M | 0.00M | 344.00 | 0.01M | 0.00M | |||||||||
| Selling, General & AdministrativeSG&A | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.01M | 0.02M | 0.00M | 0.02M | 0.03M | 0.03M | 0.03M | 0.00M | 0.00M | |||
| Other Operating ExpensesOther Opex | 0.13M | 0.16M | 0.13M | 0.02M | 0.03M | 0.02M | 0.04M | 0.08M | 0.06M | 0.11M | 0.13M | 0.10M | 0.10M | 0.13M | 0.05M | 0.08M | 0.43M | 0.11M | 0.11M | 0.13M | |||
| Operating ExpensesOpex | 0.25M | 0.36M | 0.23M | 0.09M | 0.08M | 0.05M | 0.07M | 0.11M | 0.10M | 0.17M | 0.18M | 0.15M | 0.49M | 0.21M | 0.14M | 0.18M | 0.53M | 0.20M | 0.18M | 0.20M | |||
| Operating IncomeOp. Inc | -0.36M | -0.23M | -0.09M | -0.08M | -0.05M | -0.07M | -0.11M | -0.10M | -0.17M | -0.18M | -0.15M | -0.49M | -0.21M | -0.14M | -0.18M | -0.53M | -0.20M | -0.18M | -0.20M | ||||
| EBIT | -0.25M | -0.36M | -0.23M | -0.09M | -0.08M | -0.05M | -0.07M | -0.11M | -0.10M | -0.17M | -0.18M | -0.15M | -0.49M | -0.21M | -0.14M | -0.18M | -0.53M | -0.20M | -0.18M | -0.20M | |||
| Non-operating items | |||||||||||||||||||||||
| Non Operating Interest Expenses | 0.01M | 0.01M | -0.04M | 0.01M | 0.04M | ||||||||||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | 0.10M | ||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.10M | 0.09M | -0.17M | ||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.10M | -0.06M | -0.07M | 0.12M | -0.01M | -0.04M | |||||||||||||||||
| Net income details | |||||||||||||||||||||||
| EBT | -0.25M | -0.36M | -0.23M | -0.09M | -0.08M | 0.05M | -0.07M | -0.11M | -0.10M | -0.17M | -0.18M | -0.15M | -0.49M | -0.21M | -0.14M | -0.24M | -0.59M | -0.33M | -0.19M | -0.24M | |||
| Profit After TaxPAT | -0.25M | -0.36M | -0.23M | -0.09M | -0.08M | 0.05M | -0.07M | -0.11M | -0.10M | -0.17M | -0.18M | -0.15M | -0.49M | -0.21M | -0.14M | -0.24M | -0.59M | -0.33M | -0.19M | -0.24M | |||
| Income from Continuing OperationsIncome (Continuing) | -0.25M | -0.36M | -0.23M | -0.09M | -0.08M | 0.05M | -0.07M | -0.11M | -0.10M | -0.17M | -0.18M | -0.15M | -0.49M | -0.21M | -0.14M | -0.24M | -0.59M | -0.33M | -0.19M | -0.24M | |||
| Income from Discontinued OperationsIncome (Discontinued) | |||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -0.25M | -0.36M | -0.23M | -0.09M | -0.08M | 0.05M | -0.07M | -0.11M | -0.10M | -0.17M | -0.18M | -0.15M | -0.49M | -0.21M | -0.14M | -0.24M | -0.59M | -0.33M | -0.19M | -0.24M | |||
| Income towards Parent CompanyParent Net Inc | -0.25M | -0.36M | -0.23M | -0.09M | -0.08M | 0.05M | -0.07M | -0.11M | -0.10M | -0.17M | -0.18M | -0.15M | -0.49M | -0.21M | -0.14M | -0.24M | -0.59M | -0.33M | -0.19M | -0.24M | |||
| Preferred Dividend PaymentsPref Dividends | 0.00M | ||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -0.25M | -0.36M | -0.23M | -0.09M | -0.23M | 0.05M | -0.07M | -0.11M | -0.10M | -0.17M | -0.18M | -0.15M | -0.49M | -0.21M | -0.14M | -0.24M | -0.59M | -0.33M | -0.19M | -0.24M | |||
| Additional items | |||||||||||||||||||||||
| EPS (Basic) | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | -0.02 | -0.01 | 0.00 | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | |||
| EPS (Diluted) | -0.02 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | -0.02 | -0.01 | 0.00 | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | ||||
| Shares Outstanding | 11.40M | 17.48M | 17.48M | 17.48M | 17.48M | 17.50M | 17.51M | 17.51M | 17.66M | 28.71M | 31.19M | 31.19M | 30.58M | 34.59M | 35.31M | 34.41M | 34.55M | 32.07M | 34.19M | 34.33M | |||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 17.48M | 17.48M | 17.48M | 17.48M | 32.32M | 17.51M | 17.51M | 17.51M | 28.71M | 31.19M | 31.19M | 30.58M | 34.59M | 35.31M | 34.41M | 34.55M | 32.07M | 34.19M | 34.33M | ||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 11.40M | 17.48M | 17.48M | 17.48M | 17.48M | 17.51M | 17.51M | 17.51M | 19.75M | 31.19M | 31.19M | 31.19M | 31.19M | 31.19M | 31.19M | 32.07M | 32.07M | 32.07M | 32.07M | 32.37M | |||
| Interest ExpensesInt Expense | 0.01M | 0.01M | -0.04M | 0.01M | 0.04M |
Pull Vicapsys Life Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=VICP&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "VICP", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=VICP&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();